Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

Instagram X-twitter Linkedin-in Youtube
GET IN TOUCH
image

Banasmita Kar

Senior Research Analyst
Expertise in healthcare and medical device technologies, including microbiome solutions, lab-grown ingredients, diagnostic devices like in CGM, respiratory technologies, and more.

Banasmita is skilled in technology scouting, partner identification, competitor benchmarking, and market analysis, with a strong focus on business development and technology innovation to deliver tailored solutions and drive growth.

Cases Where Banasmita Kar Worked

Insights From Banasmita Kar

Titanium Dioxide Alternatives in Pharmaceuticals

Pharmaceuticals

Technology Landscape Analysis

What Replaces TiO₂ in Pharma? These Alternatives Match Industry Benchmarks

The European Commission has recently postponed the ban on TiO2 in medicinal products due to the lack of viable alternatives. This move highlights the overreliance on TiO2 and the need

READ MORE
Microbiome gut health

Life Sciences

Startup Scouting

Microbiome Treatments Are Expanding Beyond the Gut And Changing the Healthcare Industry

In August 2025, the Microbiome Therapeutics Innovation Group (MTIG) petitioned the FDA to end the “IND loophole”. It’s a policy that allowed doctors to use unapproved stool-based (gut bacteria) treatments

READ MORE

Insights From Banasmita Kar

Resources From Banasmita Kar